TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2
- 1 November 2020
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 202 (9), 1283-1296
- https://doi.org/10.1164/rccm.201909-1884oc
Abstract
Rationale: The bHLH (basic helix-loop-helix) transcription factor TWIST1 (Twist-related protein 1) controls cell proliferation and differentiation in tissue development and disease processes. Recently, endothelial TWIST1 has been linked to pulmonary hypertension (PH) and endothelial-to-mesenchymal transition, yet the role of TWIST1 in smooth muscle cells (SMCs) remains so far unclear. Objectives: To define the role of TWIST1 in SMCs in the pathogenesis of PH. Methods: SMC-specific TWIST1-deficient mice, SMC-specific TWIST1 silencing in rats, mass spectrometry, immunoprecipitation, and chromatin immunoprecipitation were used to delineate the role of SMC TWIST1 in PH. Measurements and Main Results: In pulmonary vessels from patients with PH and rodent PH models, TWIST1 expression was markedly increased and predominantly localized to SMCs. SMC-specific TWIST1 deficiency or silencing attenuated the development of PH and distal vessel muscularization in chronically hypoxic mice and in monocrotaline-treated rats. In vitro, TWIST1 inhibition or silencing prevented pulmonary artery SMC proliferation and migration. Mechanistically, the observed effects were mediated, at least in part, by TWIST1-dependent degradation of GATA-6 (GATA-binding protein 6). BMPR2 (bone morphogenetic protein receptor-2) was identified as a novel downstream target of GATA-6, which directly binds to its promoter. Inhibition of TWIST1 promoted the recruitment of GATA-6 to the BMPR2 promoter and restored BMPR2 functional expression. Conclusions: Our findings identify a key role for SMC TWIST1 in the pathogenesis of lung vascular remodeling and in PH that is partially mediated via reduced GATA-6-dependent BMPR2 expression. Inhibition of SMC TWIST1 may constitute a new therapeutic strategy for the treatment of PH.This publication has 39 references indexed in Scilit:
- AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertensionEuropean Heart Journal, 2012
- Targeted gene delivery of BMPR2 attenuates pulmonary hypertensionEuropean Respiratory Journal, 2011
- Cellular and Molecular Basis of Pulmonary Arterial HypertensionJournal of Invasive Cardiology, 2009
- Altered Bone Morphogenetic Protein and Transforming Growth Factor-β Signaling in Rat Models of Pulmonary HypertensionJournal of the American College of Cardiology, 2009
- Hypoxia-Induced Pulmonary Vascular RemodelingCirculation Research, 2006
- Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor MetastasisCell, 2004
- Twist Regulates Cytokine Gene Expression through a Negative Feedback Loop that Represses NF-κB ActivityCell, 2003
- Mutations in TWIST, a basic helix–loop–helix transcription factor, in Saethre-Chotzen syndromeNature Genetics, 1997
- An early haematopoietic defect in mice lacking the transcription factor GATA-2Nature, 1994
- Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1Nature, 1991